Now showing items 1-2 of 2
Secondary Neoplasms of the Urinary Bladder-Clinical Management and Oncological Outcomes
Background: Secondary neoplasms of the bladder account for 4.5% of all bladder neoplasms however there is limited literature reporting management and survival. This is the largest single centre series presented in current ...
The role of URO17™ biomarker to enhance diagnosis of urothelial cancer in new haematuria patients – First European Data
Introduction and objectives: Novel biomarker research is vital for the progression of safe and thorough diagnostic medicine. There is now a need to improve the diagnosis of bladder cancer via a noninvasive urine test while ...